COVID INITIATIVES

COVID INITIATIVES

Genopole mobilized rapidly to support not only its accredited businesses and laboratories affected by the COVID-19 health crisis but also its campus neighbor, the South Île-de-France Medical Center. The ecosystem’s strength is visible therein: a united group of actors, many very aware of the weight of serious disease, enabling rapid action in an unprecedented context.

Genopole went online to keep helping its businesses. Several among them were working actively to develop tests, devices and treatments for COVID-19.

Entreprises

Genopole more than ever beside its businesses

Genopole Enterprises pursued its mission of business accompaniment online in 2020. Its habitual meetings, training sessions and workshops became webinars to help Genopole’s crisis-hamstrung businesses benefit from governmental measures, organize the resumption of activities, and shoulder the short and long-term consequences as best as possible. More than 50% of the onsite businesses responded to a survey designed to identify their needs and thus contribute to the deployment of individualized assistance and action plans. No Genopole companies went out of business because of the pandemic.

Genopole more than ever beside its businesses
  • 11,500 masks were provided to 19 businesses expressing such a need upon enquiry by Genopole. The masks were distributed on 15 May.
  • 5 webinars were organized to provide counselling to campus entities on such subjects as commercial relations strategies, governmental fiscal and social measures, and conditions for post-lockdown resumption of lab activities (HR, health protection, accounting and regulatory issues).
  • In April, Genopole surveyed its accompanied businesses to identify difficulties (reduced activity, partial unemployment, financial needs, etc.) and ease access to national measures, such as those for research tax credit reimbursements, tax postponements, and requests for state-guaranteed bank loans.
Entreprises

INTEGRAGEN MOBILIZES WITH INSTITUT PASTEUR

Institut Pasteur a world leader in infectious diseases, chose IntegraGen, a specialist in high throughput sequencing, to operate its P2M microorganism sequencing platform for the viral National Reference Centers. P2M was one of the first non-Chinese platforms to sequence the RNA of SARS-CoV-2.

INTEGRAGEN MOBILIZES WITH INSTITUT PASTEUR
Entreprises

AIINTENSE LAUNCHES A NEUROLOGY TELE-EXPERTISE NETWORK

AiiNTENSE and the Île-de-France College of Neurology have launched NeuroCOVID, a neurology tele-expertise network for the management of COVID-19 patients also affected by acute or chronic neurological disorders. With the platform, physicians can obtain a neurological collegial opinion to evaluate the impact of intensive care in this particular setting. AiiNTENSE deployed NeuroCOVID and is managing it gratuitously for the duration of the health crisis.

AIINTENSE LAUNCHES A NEUROLOGY TELE-EXPERTISE NETWORK
Entreprises

TEXCELL ABLE TO VERIFY VIRAL ELIMINATION

Texcell provides virucidal efficacy and viral clearance tests to verify the elimination of viruses in such settings as medical devices, materials disinfection, air filtration, etc. They employ carrier (or “coupon”) testing to avoid biases inherent to qPCR techniques. The company has also commercialized a seroneutralization test used for the development of therapeutic serums and compounds aimed at COVID-19.

TEXCELL ABLE TO VERIFY VIRAL ELIMINATION
Entreprises

ENALEES COMMERCIALIZES AN ULTRA-RAPID TEST

Enalees teamed with Bertin Technologies and the Institut Pasteur to develop an ultra-rapid, point-of-care COVID-19 diagnostic test able to deliver a result more reliable than those of antigen tests in less than 30 minutes. The Bec SARS-CoV-2 RT-LAMP test is referenced by the Ministry for Solidarity and Health on its COVID-19 platform.

ENALEES COMMERCIALIZES AN ULTRA-RAPID TEST
Recherche

HYBRIGENICS SERVICES PARTNERS WITH INSTITUT PASTEUR AND UVE

Hybrigenics Services is working with the Institut Pasteur and the Emergent Virus Unit (UVE-UMR190) to develop new reagents and bring progress to COVID-19 diagnostics and therapeutics. Genopole has made a cell sorter/cloner available to the company to optimize the yeast cell sorting needed for this work.

HYBRIGENICS SERVICES PARTNERS WITH INSTITUT PASTEUR AND UVE